Fortrea Holdings/$FTRE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Fortrea Holdings
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
Ticker
$FTRE
Sector
Primary listing
Industry
Life Sciences Tools and Services
Headquarters
Employees
15,000
ISIN
US34965K1079
Website
Fortrea Holdings Metrics
BasicAdvanced
$448M
-
-$8.81
1.60
-
Price and volume
Market cap
$448M
Beta
1.6
52-week high
$27.99
52-week low
$3.97
Average daily volume
2.6M
Financial strength
Current ratio
0.971
Quick ratio
0.831
Long term debt to equity
129.227
Total debt to equity
149.779
Interest coverage (TTM)
-0.92%
Profitability
EBITDA (TTM)
-19.6
Gross margin (TTM)
20.21%
Net profit margin (TTM)
-29.43%
Operating margin (TTM)
-3.82%
Effective tax rate (TTM)
-0.98%
Revenue per employee (TTM)
$180,000
Management effectiveness
Return on assets (TTM)
-1.74%
Return on equity (TTM)
-61.58%
Valuation
Price to revenue (TTM)
0.165
Price to book
0.52
Price to tangible book (TTM)
-0.43
Price to free cash flow (TTM)
3.059
Free cash flow yield (TTM)
32.69%
Free cash flow per share (TTM)
161.80%
Growth
Revenue change (TTM)
-4.45%
Earnings per share change (TTM)
464.91%
What the Analysts think about Fortrea Holdings
Analyst ratings (Buy, Hold, Sell) for Fortrea Holdings stock.
Bulls say / Bears say
Fortrea has secured strategic partnerships with top pharmaceutical customers and launched two new offerings, indicating potential for future growth. (Investing.com)
Despite recent stock price declines, Fortrea's management is implementing cost-saving measures, aiming for net savings of $40-50 million in SG&A expenses, which could improve profitability. (Investing.com)
Analysts predict that Fortrea's net income is expected to grow this year, aligning with the company's guidance for an adjusted EBITDA margin increase. (Investing.com)
Barclays downgraded Fortrea's stock rating to 'Underweight' and halved the price target to $6, citing concerns about margin improvement without corresponding revenue growth. (Investing.com)
Fortrea reported disappointing Q4 earnings, with an EPS of $0.18 and revenue of $697 million, both missing analyst estimates, leading to a 25% stock price decline. (Nasdaq)
Shareholders have filed a class-action lawsuit against Fortrea, accusing it of inflating financial projections and misleading investors, which could lead to reputational damage and financial penalties. (TradingView News)
Data summarised monthly by Lightyear AI. Last updated on 8 Jul 2025.
Fortrea Holdings Financial Performance
Revenues and expenses
Fortrea Holdings Earnings Performance
Company profitability
Fortrea Holdings News
AllArticlesVideos
Levi & Korsinsky Reminds Fortrea Holdings Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 1, 2025 – FTRE
GlobeNewsWire·18 hours ago
FTRE DEADLINE: ROSEN, A TOP-RANKED LAW FIRM, Encourages Fortrea Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – FTRE
GlobeNewsWire·2 days ago
FTRE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fortrea Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewsWire·2 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Fortrea Holdings stock?
Fortrea Holdings (FTRE) has a market cap of $448M as of July 18, 2025.
What is the P/E ratio for Fortrea Holdings stock?
The price to earnings (P/E) ratio for Fortrea Holdings (FTRE) stock is 0 as of July 18, 2025.
Does Fortrea Holdings stock pay dividends?
No, Fortrea Holdings (FTRE) stock does not pay dividends to its shareholders as of July 18, 2025.
When is the next Fortrea Holdings dividend payment date?
Fortrea Holdings (FTRE) stock does not pay dividends to its shareholders.
What is the beta indicator for Fortrea Holdings?
Fortrea Holdings (FTRE) has a beta rating of 1.6. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.